Building a better mouse model: Experimental models of chronic asthma

Clinical and Experimental Allergy

Volumn 35, Issue 10, 2005, Pages 1251-1253

  Fulkerson, P C ^b   Rothenberg, M E ^b   Hogan, S P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ASTHMA; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG INDUCED DISEASE; DRUG MEGADOSE; EDITORIAL; EFFECTOR CELL; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; IMMUNE RESPONSE; LUNG FIBROSIS; LUNG LAVAGE; LUNG REMODELLING; MOUSE; NONHUMAN; OVALBUMIN INDUCED INFLAMMATION; PRIORITY JOURNAL; TH2 CELL; ANIMAL; BRONCHUS HYPERREACTIVITY; CHRONIC DISEASE; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; MICE;

EID: 33644842209     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02354.x     Document Type: Editorial

References (43)

1. Gavett SH Chen X Finkelman F Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994 10: 587 93.
2. Hogan SP Koskinen A Matthaei KI Young IG Foster PS. Interleukin-5- producing CD4+T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998 157: 210 8.
3. Brightling CE Symon FA Birring SS Bradding P Wardlaw AJ Pavord ID. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003 58: 528 32.
4. Najafi N Demanet C Dab I De Waele M Malfroot A. Differential cytology of bronchoalveolar lavage fluid in asthmatic children. Pediatr Pulmonol 2003 35: 302 8.
5. Ward C Pais M Bish et al. Airway inflammation, basement membrane thickening and bronchial hyper-responsiveness in asthma. Thorax 2002 57: 309 16.
6. Tang W Geba GP Zheng T et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996 98: 2845 53.
7. Rankin JA Picarella DE Geba GP et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996 93: 7821 5.
8. Lee JJ McGarry MP Farmer SC et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997 185: 2143 56.
9. Zhu Z Homer RJ Wang Z et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999 103: 779 88.
10. Temann UA Ray P Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002 109: 29 39.
11. Robinson DS Hamid Q Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992 326: 298 304.
12. Brightling CE Bradding P Symon FA Holgate ST Wardlaw AJ Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002 346: 1699 705.
13. Broide DH Gleich GJ Cuomo AJ et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991 88: 637 48.
14. Wegmann M Fehrenbach H Fehrenbach A et al. Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 2005 35 (this issue).
15. McMillan SJ Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004 34: 497 507.
16. Kumar RK Herbert C Kasper M. Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma. Clin Exp Allergy 2004 34: 1796 802.
17. Johnson JR Wiley RE Fattouh R et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004 169: 378 85.
18. Busse W Elias J Sheppard D Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999 160: 1035 42.
19. Bousquet J Jeffery PK Busse WW Johnson M Vignola AM. Asthma. From bronchoconstriction to airways Inflammation and Remodelling. Am J Respir Crit Care Med 2000 161: 1720 45.
20. Roche WR Beasley R Williams JH Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989 1: 520 4.
21. Suissa S Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001 107: 937 44.
22. Doherty DE. The pathophysiology of airway dysfunction. Am J Med 2004 117 (Suppl. 12A): 11S 23S.
23. Man SF Sin DD. Inhaled corticosteroids in chronic obstructive pulmonary diseas: is there a clinical benefit? Drugs 2005 65: 579 91.
24. Temelkovski J Hogan SP Shepherd DP Foster PS Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998 53: 849 56.
25. Ordonez CL Fahy JV. Epithelial desquamation in asthma. Am J Respir Crit Care Med 2001 164: 1997.
26. Altraja A Laitinen A Virtanen I et al. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol 1996 15: 482 8.
27. Laitinen A Altraja A Kampe M Linden M Virtanen I Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997 156: 951 8.
28. Hoshino M Takahashi M Takai Y Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999 104: 356 63.
29. Flood-Page P Menzies-Gow A Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003 112: 1029 36.
30. Leigh R Ellis R Wattie J et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002 27: 526 35.
31. Cho JY Miller M Baek KJ et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004 113: 551 60.
32. Cho SH Seo JY Choi DC et al. Pathological changes according to the severity of asthma. Clin Exp Allergy 1996 26: 1210 9.
33. Leigh R Ellis R Wattie JN et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004 169: 860 7.
34. Kay AB Phipps S Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 2004 25: 477 82.
35. Wenzel SE Schwartz LB Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999 160: 1001 8.
36. Todd R Donoff BR Chiang T et al. The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol 1991 138: 1307 13.
37. Noguchi H Kephart GM Colby TV Gleich GJ. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 1992 140: 521 8.
38. Kumar RK Herbert C Webb DC Li L Foster PS. Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 2004 170: 1043 8.
39. Lee CG Homer RJ Zhu Z et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001 194: 809 21.
40. Foster PS Hogan SP Ramsay AJ Matthaei KI Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996 183: 195 201.
41. Wills-Karp M Luyimbazi J Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998 282: 2258 61.
42. Corry DB Folkesson HG Warnock ML et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996 183: 109 17.
43. Brusselle GG Kips JC Tavernier JH et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994 24: 73 80.